GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BetterLife Pharma BETR.CN · CAD

Health Care · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.21

-8.89%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2026

Net income

−C$1.5m

FY2016FY2026

Free cash flow

−C$625,455

FY2016FY2026

Shareholders' equity

−C$9.8m

FY2016FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2016
Research and developmentC$85,672C$424,337C$570,947C$2.7mC$5.4mC$284,700C$63,767C$430,456C$86,735—
Operating income−C$1.8m−C$4.7m−C$3.2m−C$9.3m−C$10.0m−C$8.0m−C$9.2m−C$6.5m−C$1.2mC$8.6m
Net income−C$1.5m−C$3.5m−C$2.9m−C$9.0m−C$12.2m−C$36.4m−C$19.6m−C$9.1m−C$149,505C$8.6m
Diluted earnings per share-0.01-0.03-0.02-0.10-0.14-0.71-1.14-0.94-0.020.11

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2016
Total assetsC$219,903C$224,963C$324,746C$74,727C$1.2mC$1.3mC$8.3mC$8.6mC$473,523C$110,000
Cash and short-term investments—————————C$70,000
Total liabilitiesC$6.7mC$7.6mC$8.0mC$7.6mC$5.0mC$5.9mC$5.6mC$5.1mC$529,513C$440,000
DebtC$27,174C$49,115C$82,495—C$34,559—————
Shareholders' equity−C$9.8m−C$10.7m−C$10.8m−C$10.7m−C$3.9m−C$4.6mC$2.7mC$3.5m−C$55,990C$330,000
Shares outstanding152m130m116m90m85m51m17m10m8m—

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2016
Cash from operations−C$625,455−C$2.0m−C$2.5m−C$1.5m−C$11.2m−C$7.2m−C$7.9m−C$4.7m−C$561,521C$160,000
Capital spending—————−C$10,153−C$542,742−C$542,742−C$542,742—
Free cash flow−C$625,455−C$2.0m−C$2.5m−C$1.5m−C$11.2m−C$7.2m−C$8.4m−C$5.3m−C$1.1mC$160,000

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Operating income−C$1.2m−C$561,395−C$437,008−C$389,215−C$511,630−C$470,747−C$632,265−C$714,368
Net income−C$2.1m−C$609,257−C$380,547−C$409,014−C$494,476−C$211,454−C$735,670C$601,651
Diluted earnings per share-0.01-0.00-0.00-0.00-0.00-0.00-0.010.00
Cash from operations−C$1.0m———————
Total assetsC$2.0mC$242,428C$219,903C$291,127C$229,340C$231,860C$224,963C$271,376
DebtC$26,327C$27,677C$27,174C$95,954C$53,613C$51,278C$49,115C$808,888
Shareholders' equity−C$10.9m−C$9.7m−C$9.8m−C$9.5m−C$9.1m−C$9.4m−C$10.7m−C$10.0m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-42.0%-25.6%—
Net income-45.1%-47.2%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-23.4-1.8-4.0-0.6-1.1-0.3-1.8-1.0-101.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 26 Jun 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.